{
    "medicine_id": "4d7d6e327f2df57f740b0acab21ace6ec22758ef",
    "platform_id": "7108",
    "metadata": {
        "name": "Ribavirin 200 mg film coated tablets",
        "composition": "Each film coated tablet contains 200 mg of ribavirin For the full list of",
        "clinical_particulars": {
            "therapeutic_indications": "Ribavirin is indicated in combination with other medicinal products for the treatment of chronic hepatitis C CHC",
            "contraindications": {
                "disease": "Ribavirin is contraindicated in the following hypersensitivity to ribavirin or to any of the excipients listed in section 6 1 pregnant women see section 4 4 Ribavirin must not be initiated until a report of a negative pregnancy test has been obtained immediately prior to initiation of therapy women who are breast feeding see section 4 6 a history of severe pre existing cardiac disease including unstable or uncontrolled cardiac disease in the previous six months haemoglobinopathies e g thalassaemia sickle cell anaemia Refer also to the SmPC of the medicinal products that are used in combination with ribavirin for contraindications related to those products",
                "pregnancy": "Applicable",
                "machine_ops": "Applicable",
                "excipients": ";Cellulose, microcrystalline;Starch, pregelatinised (Maize starch);Sodium starch glycolate (Type A);Povidone (K-30);Silica, colloidal anhydrous;Magnesium stearate;;HPMC 2910/ Hypromellose (15cP) (E464);Titanium dioxide (E171);Triacetin (E1518);Iron oxide red (E172);Iron oxide yellow (E172);Ethyl cellulose (10cP) (E462)",
                "incompatibilities": "Not applicable"
            }
        },
        "revision_date": "2022-07-21"
    }
}